MoneyWorks4Me

Panacea Biotec - Quaterly Results

18 May 2022 Evaluate
A decrease of about -48.03% in the sales to Rs. 415.00 millions was observed for the quarter ended March 2022. The sales stood at Rs. 798.60 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2022 is Rs. -253.10 millions as compared to Net Loss of Rs. -183.10 millions of corresponding quarter ended March 2021 Operating profit Margin for the quarter ended March 2022 further decreased to -168.10% as compared to -83.60% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 415.00 798.60 -48.03 2355.00 3435.60 -31.45 2355.00 3435.60 -31.45
Other Income 25.70 77.50 -66.84 125.70 207.40 -39.39 125.70 207.40 -39.39
PBIDT -168.10 -83.60 101.08 -601.10 212.40 -383.00 -601.10 212.40 -383.00
Interest 14.40 18.60 -22.58 70.40 75.20 -6.38 70.40 75.20 -6.38
PBDT -182.50 -102.20 78.57 -671.50 137.20 -589.43 -671.50 137.20 -589.43
Depreciation 70.60 65.70 7.46 264.30 265.70 -0.53 264.30 265.70 -0.53
PBT -253.10 -167.90 50.74 -935.80 -128.50 628.25 -935.80 -128.50 628.25
TAX 0.00 15.20 0.00 0.00 15.60 0.00 0.00 15.60 0.00
Deferred Tax 0.00 -7.50 0.00 0.00 -7.10 0.00 0.00 -7.10 0.00
PAT -253.10 -183.10 38.23 -935.80 -144.10 549.41 -935.80 -144.10 549.41
Equity 61.30 61.30 0.00 61.30 61.30 0.00 61.30 61.30 0.00
PBIDTM(%) -40.51 -10.47 286.94 -25.52 6.18 -512.86 -25.52 6.18 -512.86
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..